PNC Financial Services Group
ALDR

PNC Financial Services Group’s Alder Biopharmaceuticals ALDR Stock Holding History

PNC Financial Services Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-18
Closed – – 4350
2018
Q1 		$0 Hold
18
– – ﹤0.01% 4346
2017
Q4 		$0 Buy
+18
New +$201 ﹤0.01% 4315
2017
Q2 		– Sell
-4,260
Closed -$88K – 4274
2017
Q1 		$88K Hold
4,260
– – ﹤0.01% 2578
2016
Q4 		$88K Hold
4,260
– – ﹤0.01% 2538
2016
Q3 		$140K Buy
4,260
+4,137
+3,363% +$126K ﹤0.01% 2298
2016
Q2 		$3K Buy
123
+26
+27% +$703 ﹤0.01% 4087
2016
Q1 		$2K Buy
97
+3
+3% +$69 ﹤0.01% 4264
2015
Q4 		$3K Hold
94
– – ﹤0.01% 4082
2015
Q3 		$3K Sell
94
-279
-75% -$11.9K ﹤0.01% 4196
2015
Q2 		$20K Sell
373
-37,407
-99% -$1.36M ﹤0.01% 3509
2015
Q1 		$1.09M Buy
37,780
+37,772
+472,150% +$1.04M ﹤0.01% 1226
2014
Q4 		$0 Buy
+8
New +$144 ﹤0.01% 4305

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PNC Financial Services Group's ALDR Position: Q2 2018 in Review

PNC Financial Services Group sold out of Alder Biopharmaceuticals (ALDR) in Q2 2018, closing a stake of 18 shares.

PNC Financial Services Group first reported a position in ALDR in Q4 2014 and held it in 12 quarters. The position peaked at $1.09M in Q1 2015. 139 funds tracked by Wall St. Rank hold ALDR as of Q2 2018.

  • PNC Financial Services Group reported no remaining Alder Biopharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • PNC Financial Services Group sold 18 Alder Biopharmaceuticals shares in Q2 2018.
  • PNC Financial Services Group first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 12 quarters.
  • PNC Financial Services Group's Alder Biopharmaceuticals position peaked at $1.09M in Q1 2015.
  • 139 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2018.

Based on PNC Financial Services Group's 13F filing for Q2 2018, filed 10 Aug 2018.